0001829126-25-009432 Sample Contracts
LOAN SETTLEMENT AGREEMENTLoan Settlement Agreement • November 25th, 2025 • KALA BIO, Inc. • Pharmaceutical preparations
This Loan Settlement Agreement (hereinafter referred to as “Settlement Agreement”) is entered into on November 23, 2025 by and among OXFORD FINANCE LLC, a Delaware limited liability company with an office located at 115 South Union Street, Suite 300, Alexandria, Virginia 22314 (in its individual capacity, “Oxford”; and in its capacity as Collateral Agent, “Collateral Agent”), the Lenders listed on Schedule 1.1 to the Loan Agreement (as defined herein) from time to time including Oxford in its capacity as a Lender (each a “Lender” and collectively, the “Lenders”) and KALA BIO, INC., a Delaware corporation with an office located at 1167 Massachusetts Avenue, Arlington, MA 02476 (formerly known as KALA PHARMACEUTICALS, INC.) (“Kala”) and COMBANGIO, INC., a Delaware corporation with office located at 1167 Massachusetts Avenue, Arlington, MA 02476 (“Combangio,” and, together with Kala, individually and collectively, jointly and severally, “Borrower”); hereinafter referred to as the “Parties
VOTING AGREEMENTVoting Agreement • November 25th, 2025 • KALA BIO, Inc. • Pharmaceutical preparations • Delaware
THIS VOTING AGREEMENT (this “Agreement”) is being signed on November 23, 2025 (the “Signature Date”) by and among (a) Kala Bio, Inc. a Delaware corporation whose Common Stock is listed for trading on the Nasdaq (the “Proxy” or the “Company”), (b) Mr. David Elliot Lazar, an individual (“Lazar”), and (c) OXFORD FINANCE LLC, a Delaware limited liability company (the “Stockholder”).
SETTLEMENT AGREEMENT AND GENERAL AND MUTUAL RELEASESettlement Agreement • November 25th, 2025 • KALA BIO, Inc. • Pharmaceutical preparations • Delaware
This Settlement Agreement and General and Mutual Release (the “Agreement”) is entered into as of the date set forth in the signature block of this Agreement by and between KALA BIO Inc. (the “Company”) and _____________, the __________ of the Company (“Officer”), collectively known herein as the “Parties.”
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 25th, 2025 • KALA BIO, Inc. • Pharmaceutical preparations • New York